Galecto Biotech (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 3 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

M&A and Exit deals (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Companies with similar profile to Galecto Biotech:

CompanyCriteria
Denmark NMD Pharma
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Draupnir Bio
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sunstone Life Science Ventures
  • At least one other investor: Merck Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
64%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark MinervaX
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sunstone Life Science Ventures, Seed Capital
  • Total raised in a similar range: 10M+ USD
Sweden AMRA
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners, Sunstone Life Science Ventures, Seed Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Aprea Therapeutics
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Mobidiag
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Unibio
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Anaconda Biomed
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Merozyne Therapeutics
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Antag
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds